SCHEMBL4650207

SCHEMBL4650207

COC(=O)c1cccc(NC(=O)OCc2ccccc2)c1CO

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
CYP2C19 P33261 2/20 0.53
CYP1A2 P05177 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 3/20 0.51
GAA P10253 2/20 0.51
KMT2A Q03164 3/20 0.49
CASP3 P42574 1/20 0.48
HSD17B10 Q99714 2/20 0.46
MGLL Q99685 1/20 0.46
PLAU P00749 1/20 0.46
PTPN1 P18031 1/20 0.46
MAPK10 P53779 2/20 0.46
POLB P06746 2/20 0.46
MEN1 O00255 2/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
RAF1 P04049 1/20 0.45
BRAF P15056 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10192673 0.89 NPC1 (0.56) NPC1RAB9ACYP2C19CYP1A2SMN1; SMN2
SCHEMBL10874779 0.88 NPC1 (0.68) NPC1RAB9ACYP2C19CYP1A2SMN1; SMN2
SCHEMBL10192674 0.85 NPC1 (0.64) NPC1RAB9ACYP2C19CYP1A2SMN1; SMN2
SCHEMBL9686398 0.83 NPC1 (0.74) NPC1RAB9ASMN1; SMN2ALDH1A1CASP3
SCHEMBL5056843 0.81 CYP2C19 (0.60) NPC1RAB9ACYP2C19CYP1A2SMN1; SMN2
SCHEMBL5241284 0.81 RAB9A (0.55) NPC1RAB9ACYP2C19CYP1A2SMN1; SMN2
SCHEMBL27567788 0.80 CYP1A2 (0.63) NPC1RAB9ACYP2C19CYP1A2SMN1; SMN2
SCHEMBL11092094 0.79 NPC1 (0.56) NPC1RAB9ACYP2C19CYP1A2SMN1; SMN2
SCHEMBL27523120 0.78 CYP1A2 (0.60) NPC1RAB9ACYP2C19CYP1A2SMN1; SMN2
SCHEMBL2233522 0.78 NPC1 (0.69) NPC1RAB9ASMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1968954-A1 MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS Novartis AG (CH) 2008-09-17 EP disclosed
WO-2007077004-A1 MACROCYCLIC COMPOUNDS USEFUL AS BACE INHIBITORS NOVARTIS AG (CH) 2007-07-12 WO disclosed